These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 16547857

  • 1. The prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Osmanoğlu N, Tekin F, Ozütemiz O, Ersöz G, Tekeşin O.
    Turk J Gastroenterol; 2005 Dec; 16(4):240-1. PubMed ID: 16547857
    [No Abstract] [Full Text] [Related]

  • 2. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U, Bergquist A.
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Colorectal neoplasia in PSC-IBD patients: are times changing?
    Sokol H, Chazouilleres O.
    Liver Int; 2012 Feb; 32(2):175-6. PubMed ID: 22226230
    [No Abstract] [Full Text] [Related]

  • 5. [Inflammatory intestinal diseases and primary sclerosing cholangitis].
    Neĭman KP, Golovanova EV, Rumiantsev VG, Il'chenko LIu.
    Eksp Klin Gastroenterol; 2008 Feb; (2):62-9. PubMed ID: 19145868
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Primary sclerosing cholangitis].
    Färkkilä M.
    Duodecim; 1993 Feb; 109(4):281-8. PubMed ID: 8013332
    [No Abstract] [Full Text] [Related]

  • 10. Severe complications of inflammatory bowel disease.
    Marrero F, Qadeer MA, Lashner BA.
    Med Clin North Am; 2008 May; 92(3):671-86, ix. PubMed ID: 18387381
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sclerosing cholangitis.
    MacFaul GR, Chapman RW.
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.
    Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS.
    Am J Gastroenterol; 2007 May; 102(5):1042-9. PubMed ID: 17313496
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
    Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M.
    Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
    [Abstract] [Full Text] [Related]

  • 17. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden.
    Bergquist A, Said K, Broomé U.
    Scand J Gastroenterol; 2007 Jan; 42(1):88-93. PubMed ID: 17190768
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR.
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [Abstract] [Full Text] [Related]

  • 20. Primary sclerosing cholangitis: the gut-liver axis.
    Tabibian JH, O'Hara SP, Larusso NF.
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):819; author reply 819-20. PubMed ID: 22343691
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.